ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 184692 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 184692; 2) Community: the network communities that were significantly associated with the response to NSC 184692; 3) Molecule: the relationships between components within communities and NSC 184692; 4) MDR: the compounds that were significantly associated with the NSC 184692.

NSC Compound Enrichment Correlation
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0454469012959173 0.50536708
NSC 663334 Null 0.0454469012959173 0.34052518
NSC 667904 1-(8-(2,3-dimethoxyphenyl)-7-methyl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromen-6-yl)-2-phenylhydrazine 0.0454469012959173 0.24477696
NSC 668476 Null 0.0454469012959173 0.069654181
NSC 669888 Null 0.0454469012959173 0.368906
NSC 675000 Null 0.0454469012959173 0.29768936
NSC 677672 Null 0.0454469012959173 0.20488187
NSC 677776 Null 0.0454469012959173 -0.21330463
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0454469012959173 0.15179598
NSC 681636 Camptothecin Derivative 0.0454469012959173 0.54074267
Total:130  Current:121    [First] [Prev] [Next] [Last]